PYC Therapeutics Secures US FDA's Rare Pediatric Disease Designation for Eye Disease Medication; Shares Hit 52-Week High
PYC Therapeutics Secures US FDA's Rare Pediatric Disease Designation for Eye Disease Medication; Shares Hit 52-Week High
PYC Therapeutics爲眼科藥物獲得美國FDA的罕見兒科疾病認可;股價創下52周高點
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊